---
figid: PMC8514848__gr1
figtitle: 'RASopathies: From germline mutations to somatic and multigenic diseases'
organisms:
- Homo sapiens
- Rattus norvegicus
- Lareunionomyces loeiensis
- unidentified
- Panthera pardus
- Campylobacter upsaliensis
pmcid: PMC8514848
filename: gr1.jpg
figlink: /pmc/articles/PMC8514848/figure/fig1/
number: F1
caption: 'RAS/MAPK pathway and proteins involved in RAS-associated diseases. Overview
  of the RAS-MAPK pathway activation process from the detection of stimuli (here growth
  factor) by tyrosine kinase receptors (RTK) to the phosphorylation of ERK1 and 2.
  Diseases associated with mutations in the pathway are indicated in dark blue for
  germline diseases and dark yellow for somatic ones. Increased phosphorylated ERK1/2
  in RAS-associated autoimmune leukoproliferative disorders (RALD) participate in
  BIM degradation, impairing activation autonomous cell-death (ACAD). NS: Noonan syndrome,
  NF1: Neurofibromatosis type 1, CFC: Cardio-facio-cutaneous syndrome, NSML: Noonan
  syndrome with multiple lentigines, CM-AVM: capillary malformation-arteriovenous
  malformation syndrome, LS: Legius syndrome, ECD: Erdheim-Chester disease, RDD: Destombes-Rosai-Dorfman,
  LCH: Langerhans-cell histiocytosis.'
papertitle: 'RASopathies: From germline mutations to somatic and multigenic diseases.'
reftext: Quentin Riller, et al. Biomed J. 2021 Aug;44(4):422-432.
year: '2021'
doi: 10.1016/j.bj.2021.06.004
journal_title: Biomedical Journal
journal_nlm_ta: Biomed J
publisher_name: Chang Gung University
keywords: RAS | Somatic | Germline | Monocytes | Histiocytes | Lymphoproliferation
automl_pathway: 0.915116
figid_alias: PMC8514848__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Panthera pardus
redirect_from: /figures/PMC8514848__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8514848__gr1.html
  '@type': Dataset
  description: 'RAS/MAPK pathway and proteins involved in RAS-associated diseases.
    Overview of the RAS-MAPK pathway activation process from the detection of stimuli
    (here growth factor) by tyrosine kinase receptors (RTK) to the phosphorylation
    of ERK1 and 2. Diseases associated with mutations in the pathway are indicated
    in dark blue for germline diseases and dark yellow for somatic ones. Increased
    phosphorylated ERK1/2 in RAS-associated autoimmune leukoproliferative disorders
    (RALD) participate in BIM degradation, impairing activation autonomous cell-death
    (ACAD). NS: Noonan syndrome, NF1: Neurofibromatosis type 1, CFC: Cardio-facio-cutaneous
    syndrome, NSML: Noonan syndrome with multiple lentigines, CM-AVM: capillary malformation-arteriovenous
    malformation syndrome, LS: Legius syndrome, ECD: Erdheim-Chester disease, RDD:
    Destombes-Rosai-Dorfman, LCH: Langerhans-cell histiocytosis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACAD8
  - ACAD9
  - ACADL
  - ACADM
  - ACADS
  - ACADVL
  - ACAD10
  - ACAD11
  - ACADSB
  - GCDH
  - IVD
  - KRAS
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - APAF1
  - BAX
  - BAK1
  - BCL2L11
  - BCL2
  - MAPK3
  - MAPK1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PTPN11
  - HRAS
  - NRAS
  - SPRED1
  - TBCC
  - ECD
  - SEM1
  - BRAF
  - DRD1
  - DRD2
  - DRD3
  - DRD4
  - DRD5
  - CS
  - MAP2K1
  - CBL
  - NF1
  - ARAF
  - RAF1
  - MAP2K2
  - RASA1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTG1
  - Apaf1
  - Bax
  - Bak1
  - Bcl2l11
  - Bcl2
  - Mapk3
  - Mapk1
  - Ptpn11
  - Spred1
  - Ecd
  - Braf
  - Cs
  - Hras
  - Nras
  - Kras
  - Map2k1
  - Cbl
  - Nf1
  - Araf
  - Akt1
  - Mtor
  - Pik3cg
  - Pck1
---
